Cure My Disease

Don't miss your cure!

 Log in / Sign up

New brain chemical mimic could help people stay awake

NCT ID NCT06952699

Recruiting now Disease control Sponsor: Takeda Source: ClinicalTrials.gov ↗

Summary

This study is testing an experimental medication called TAK-360 for adults with narcolepsy type 2, a condition that causes severe daytime sleepiness. Researchers want to find a safe and effective dose that helps people stay awake and alert. About 88 participants will be randomly assigned to receive either the real medication or a placebo pill to compare the effects.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NARCOLEPSY TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Takeda Site 1

    RECRUITING

    Colorado Springs, Colorado, 80918-3408, United States

  • Takeda Site 10

    RECRUITING

    Santa Ana, California, 92705-8519, United States

  • Takeda Site 11

    RECRUITING

    Norfolk, Virginia, 23510-1021, United States

  • Takeda Site 12

    RECRUITING

    Yodogawa-ku, Osaka-shi, Ôsaka, 532-0003, Japan

  • Takeda Site 13

    RECRUITING

    Brandon, Florida, 33511-5719, United States

  • Takeda Site 14

    RECRUITING

    Redwood City, California, 94063-3132, United States

  • Takeda Site 15

    RECRUITING

    Paris, 75013, France

  • Takeda Site 16

    RECRUITING

    Junggu, Daegu Gwang'yeogsi, South Korea

  • Takeda Site 17

    WITHDRAWN

    Montpellier, Hérault, 34090, France

  • Takeda Site 18

    RECRUITING

    Madrid, 28046, Spain

  • Takeda Site 19

    RECRUITING

    Suwon, Gyeonggido, 16247, South Korea

  • Takeda Site 2

    RECRUITING

    Columbia, South Carolina, 29201-2923, United States

  • Takeda Site 20

    RECRUITING

    Shinjuku-ku, Tokyo, 162-0851, Japan

  • Takeda Site 21

    RECRUITING

    Seoul, Seoul Teugbyeolsi, 3080, South Korea

  • Takeda Site 22

    RECRUITING

    Rome, Lazio, 133, Italy

  • Takeda Site 23

    RECRUITING

    Bologna, 40139, Italy

  • Takeda Site 24

    RECRUITING

    Kohoku-ku, Yokohama-Shi, Kanagawa, 222-0033, Japan

  • Takeda Site 26

    RECRUITING

    Sumida-Ku, Tokyo, 130-0004, Japan

  • Takeda Site 27

    RECRUITING

    Shanghai, Shanghai Municipality, 200040, China

  • Takeda Site 28

    RECRUITING

    Beijing, Beijing Municipality, 100053, China

  • Takeda Site 29

    RECRUITING

    Guangzhou, Guangzhou, 510515, China

  • Takeda Site 3

    RECRUITING

    Orlando, Florida, 32803-1468, United States

  • Takeda Site 30

    RECRUITING

    Urasoe-Shi, Okinawa, 901-2132, Japan

  • Takeda Site 31

    RECRUITING

    Verona, Veneto, 37134, Italy

  • Takeda Site 4

    RECRUITING

    St Louis, Missouri, 63123-6968, United States

  • Takeda Site 5

    RECRUITING

    Cincinnati, Ohio, 45245-4500, United States

  • Takeda Site 6

    RECRUITING

    Huntersville, North Carolina, 28078-5082, United States

  • Takeda Site 7

    RECRUITING

    San Antonio, Texas, 78229-4849, United States

  • Takeda Site 8

    RECRUITING

    Denver, North Carolina, 28037, United States

  • Takeda Site 9

    RECRUITING

    Kumamoto, Kumamoto, 862-0954, Japan

Conditions

Explore the condition pages connected to this study.

NARCOLEPSY TYPE 2